NasdaqGM - Nasdaq Real Time Price
USD
Harmony Biosciences Holdings, Inc. (HRMY)
38.76
+0.17
(+0.44%)
At close: October 30 at 4:00:01 PM EDT
38.63
-0.13
(-0.34%)
After hours: October 30 at 7:36:26 PM EDT
Trade HRMY on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreInsider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BUDUR KUMAR Officer |
Sale | Sep 8, 2026 | 13,115 |
| DAYNO JEFFREY M Chief Executive Officer |
Conversion of Exercise of derivative security | Jan 23, 2026 | 7,346 |
| DIERKS JEFFREY G Officer |
Sale | Mar 3, 2025 | 0 |
| KAPADIA SANDIP Chief Financial Officer |
Sale | Jan 26, 2026 | 24,521 |
| MARSHMAN FUND TRUST II Beneficial Owner of more than 10% of a Class of Security |
Sale | Nov 5, 2024 | 6,051,120 |
| SERAFIN ANDREW Officer |
Conversion of Exercise of derivative security | Jan 23, 2026 | 1,474 |
| VALOR EQUITY PARTNERS Beneficial Owner of more than 10% of a Class of Security |
Sale | Nov 5, 2024 | 6,618,030 |
| VALOR IV PHARMA HOLDINGS L.L.C. Beneficial Owner of more than 10% of a Class of Security |
Sale | Nov 5, 2024 | 6,618,030 |
| ZAESKE ADAM H. Officer |
Conversion of Exercise of derivative security | Apr 7, 2026 | 4,327 |
